Catalio Capital Management, LP - Stock Holdings in 13F Filings (SEC)
Updated on March 15, 2026.
Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, Catalio Capital Management, LP held in its portfolio 45 assets valued at $565,790,302 (i.e. $565.79M).
The most valuable assets in the portfolio included: GILEAD SCIENCES INC ($35.51M), BRISTOL-MYERS SQUIBB CO ($34.95M), and BOSTON SCIENTIFIC CORP ($34.37M).
The chart below shows the top 10 valuable assets, and the table below shows the top 45 valuable assets.
You can see similar for other investment managers.
Related Topics: SEC Topic List.
Data Source: SEC.
Catalio Capital Management, LP - Stock Holdings in 13F Filings (SEC)
Items per page:
25
0 of 0
| Name of Issuer | No. of Shares | Value ($) | Class |
|---|---|---|---|
| GILEAD SCIENCES INC | 289312 | 35510155 | COM |
| BRISTOL-MYERS SQUIBB CO | 647899 | 34947672 | COM |
| BOSTON SCIENTIFIC CORP | 360428 | 34366810 | COM |
| BRIDGEBIO ONCOLOGY THERAPEUT | 410700 | 31414443 | COM NEW |
| ELI LILLY & CO | 25923 | 27858930 | COM |
| DIANTHUS THERAPEUTICS INC | 653572 | 26933702 | COM |
| ASCENDIS PHARMA A/S | 119265 | 25432069 | SPONSORED ADR |
| SYNDAX PHARMACEUTICALS INC | 1196807 | 25144915 | COM |
| JOHNSON & JOHNSON | 120840 | 25007838 | COM |
| REGENERON PHARMACEUTICALS | 29797 | 22999410 | COM |
| STRUCTURE THERAPEUTICS INC | 252901 | 17589265 | SPONSORED ADS |
| SOLENO THERAPEUTICS INC | 360340 | 16683742 | COM |
| CYTOKINETICS INC | 258381 | 16417529 | COM NEW |
| EDWARDS LIFESCIENCES CORP | 187048 | 15945842 | COM |
| INTUITIVE SURGICAL INC | 27209 | 15410089 | COM NEW |
| NATERA INC | 62273 | 14266122 | COM |
| ADAPTIVE BIOTECHNOLOGIES COR | 821195 | 13336207 | COM |
| ABIVAX SA | 98514 | 13285105 | SPONSORED ADS |
| SUPERNUS PHARMACEUTICALS INC | 257465 | 12796011 | COM |
| FRACTYL HEALTH INC | 5491866 | 12082105 | COM |
| MINERALYS THERAPEUTICS INC | 331849 | 12042800 | COM |
| PHATHOM PHARMACEUTICALS INC | 698996 | 11596344 | COM |
| ADMA BIOLOGICS INC | 564461 | 10295769 | COM |
| ARCELLX INC | 156109 | 10178307 | COMMON STOCK |
| DYNE THERAPEUTICS INC | 519715 | 10165625 | COM |
| DISC MEDICINE INC | 110427 | 8769008 | COM |
| OCULAR THERAPEUTIX INC | 714501 | 8674042 | COM |
| SEPTERNA INC | 294360 | 8206757 | COM |
| PROTARA THERAPEUTICS INC | 1446254 | 7708534 | COM STK |
| UNIQURE NV | 288345 | 6900096 | SHS |
| OLEMA PHARMACEUTICALS INC | 267058 | 6676450 | COM |
| TERNS PHARMACEUTICALS INC | 136958 | 5533103 | COM |
| ULTRAGENYX PHARMACEUTICAL IN | 162550 | 3738650 | COM |
| HEARTFLOW INC | 113857 | 3318932 | COM |
| GRAIL INC | 30313 | 2594490 | COM |
| FULCRUM THERAPEUTICS INC | 201301 | 2276714 | COM |
| BILLIONTOONE INC | 25505 | 2087329 | CL A |
| ELEDON PHARMACEUTICALS INC | 1259820 | 1902328 | COM |
| HYPERFINE INC | 1320041 | 1292716 | COM CL A |
| PALVELLA THERAPEUTICS INC NE | 10452 | 1094011 | COM |
| KARYOPHARM THERAPEUTICS INC | 142984 | 1052362 | COM NEW |
| METAGENOMI INC | 528993 | 856969 | COM |
| ATAI BECKLEY NV | 196858 | 805149 | SHS |
| OUTSET MED INC | 118279 | 438815 | COM NEW |
| SENSEI BIOTHERAPEUTICS INC | 14718 | 157041 | COM NEW |